172@29@17@104!~!172@29@0@53!~!|news|tags|glenmark-pharma.html!~!|controller|tag.php
glenmark pharma
Jump to
1210 Results Found
  • DCGI seeks clarification from Glenmark Pharma on its claim of FabiFlu use for COVID-19 patients with comorbidities Jul 19, 2020 08:30 PM IST

    DCGI seeks clarification from Glenmark Pharma on its claim of FabiFlu use for COVID-19 patients with comorbidities

    Glenmark Pharmaceuticals had on July 13 said it has cut the price of its antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19 by 27 percent to Rs 75 per tablet.

  • Neutral Glenmark Pharma; target of Rs 430: Motilal Oswal Jul 01, 2020 11:02 AM IST

    Neutral Glenmark Pharma; target of Rs 430: Motilal Oswal

    Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 430 in its research report dated June 29, 2020.

  • Glenmark Pharma share price tumbles 5% on price-fixing allegations in US Jul 01, 2020 10:37 AM IST

    Glenmark Pharma share price tumbles 5% on price-fixing allegations in US

    The charge was filed in US District Court in Philadelphia. The price-fixing conspiracy allegedly took place from 2013 to 2015 and caused a loss to victims of at least $200 million, according to the department.

  • Buy Glenmark Pharma; target of Rs 526: Emkay Global Financial Jul 01, 2020 10:31 AM IST

    Buy Glenmark Pharma; target of Rs 526: Emkay Global Financial

    Emkay Global Financial is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 526 in its research report dated June 29, 2020.

  • Glenmark Standalone March 2020 Net Sales at Rs 1,607.73 crore, up 1.29% Y-o-Y Jun 29, 2020 11:11 AM IST

    Glenmark Standalone March 2020 Net Sales at Rs 1,607.73 crore, up 1.29% Y-o-Y

  • Glenmark Consolidated March 2020 Net Sales at Rs 2,767.49 crore, up 7.96% Y-o-Y Jun 29, 2020 10:15 AM IST

    Glenmark Consolidated March 2020 Net Sales at Rs 2,767.49 crore, up 7.96% Y-o-Y

  • Buy Glenmark Pharma; target of Rs 488: ICICI Securities Jun 25, 2020 07:49 AM IST

    Buy Glenmark Pharma; target of Rs 488: ICICI Securities

    ICICI Securities is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 488 in its research report dated June 22, 2020.

  • COVID-19 impact | Will Favipiravir approval help Glenmark Pharma catch up with peers? Jun 22, 2020 04:29 PM IST

    COVID-19 impact | Will Favipiravir approval help Glenmark Pharma catch up with peers?

    The company has started manufacturing favipiravir and will release it in the market in a few days, giving it the first-mover advantage.

  • Glenmark shares end 27% higher after regulator's nod for COVID-19 drug Jun 22, 2020 10:10 AM IST

    Glenmark shares end 27% higher after regulator's nod for COVID-19 drug

    The pharma company said that it has received Indian regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to-moderate COVID-19 infections .

  • Glenmark Pharma share price up 9% on nod to trials for possible COVID-19 drug Apr 30, 2020 12:39 PM IST

    Glenmark Pharma share price up 9% on nod to trials for possible COVID-19 drug

    Favipiravir has demonstrated activity against influenza viruses and has been approved in Japan for the treatment of novel influenza virus infections, the company has said.

  • Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tablets Apr 29, 2020 10:58 AM IST

    Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tablets

    The approval granted by the United States Food and Drug Administration (USFDA) to Glenmark Pharmaceuticals Inc., USA, is for the strength of 10 mg/5 mg tablets, the generic version of Qtern tablets of the same strength of AstraZeneca AB, the company said in a statement.

  • Glenmark gets tentative nod from USFDA for generic type-2 diabetes tablets Mar 23, 2020 01:38 AM IST

    Glenmark gets tentative nod from USFDA for generic type-2 diabetes tablets

    "Glenmark Pharmaceuticals Inc USA has been granted tentative approval by the United States Food and Drug Administration (USFDA) for Dapagliflozin tablets, 5 mg and 10 mg," Glenmark said in a filing to BSE.

  • Glenmark Pharma sells gynaecology business, share price gains Jan 22, 2020 11:27 AM IST

    Glenmark Pharma sells gynaecology business, share price gains

    The share touched its 52-week high Rs 668.25 and 52-week low Rs 267.30 on 16 January, 2019 and 14 November, 2019, respectively.

  • Granules India, Glenmark Pharma rally 3% on drug approvals from USFDA Jan 07, 2020 10:09 AM IST

    Granules India, Glenmark Pharma rally 3% on drug approvals from USFDA

    Granules India got the nod for a painkiller, while Glenmark got it for Deferasirox tablets used in the treatment for chronic iron overload syndrome.

  • Glenmark Pharma receives GMP certificate from European regulator; share price gains 3% Dec 16, 2019 10:09 AM IST

    Glenmark Pharma receives GMP certificate from European regulator; share price gains 3%

    The share touched its 52-week high Rs 706.90 and 52-week low Rs 267.30 on 31 December, 2018 and 14 November, 2019, respectively.

  • Glenmark Pharma share price ends 22% higher after CLSA upgrades stock to buy Nov 18, 2019 10:13 AM IST

    Glenmark Pharma share price ends 22% higher after CLSA upgrades stock to buy

    CLSA is of the view that the US sales momentum is expected to remain strong while India business should continue growing above the industry rate

  • Glenmark Pharma share price jumps 4% after Q2 profit at Rs 255 cr Nov 15, 2019 09:56 AM IST

    Glenmark Pharma share price jumps 4% after Q2 profit at Rs 255 cr

    The net sales of the company stood at Rs 2,763.73 crore, up 8.81 percent, during the period under review as against Rs 2,539.85 crore of the corresponding quarter previous fiscal.

  • Glenmark Pharma gets USFDA nod for prostate cancer treatment drug Oct 17, 2019 11:11 AM IST

    Glenmark Pharma gets USFDA nod for prostate cancer treatment drug

    "Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Abiraterone Acetate tablets USP, 250 mg," the company said in a regulatory filing.

  • Glenmark Pharma to raise up to $200 million Sep 28, 2019 02:40 PM IST

    Glenmark Pharma to raise up to $200 million

    The proposal was approved at the company's annual general meeting held on September 27.

  • Glenmark Pharma gains on ODD for treatment of multiple myeloma Sep 17, 2019 10:09 AM IST

    Glenmark Pharma gains on ODD for treatment of multiple myeloma

    Company said GBR 1342 is designed to bind to both CD3 on T cells and CD38, an antigen known to be implicated in hematological malignancies, on target cells.

  • Glenmark gains 4% after USFDA issues no observations for Indore unit Sep 16, 2019 11:01 AM IST

    Glenmark gains 4% after USFDA issues no observations for Indore unit

    The US Food and Drug Administration inspected company's Indore unit last week during September 9-13.

  • Glenmark Pharma falls 4% as CLSA maintains sell amid weak earnings, high debts Sep 13, 2019 12:11 PM IST

    Glenmark Pharma falls 4% as CLSA maintains sell amid weak earnings, high debts

    The brokerage sees weak earnings trajectory and high leverage as areas of concern.

  • Glenmark Pharma hits 8-yr low after global brokerages cut price target on weak Q1 results Aug 16, 2019 11:29 AM IST

    Glenmark Pharma hits 8-yr low after global brokerages cut price target on weak Q1 results

    While maintaining neutral rating, Credit Suisse also slashed its price target to Rs 415 from Rs 600 after cutting FY20/21 EPS estimates by 24/16 percent to factor in weak Q1.

  • Glenmark Pharma Q1 PAT may dip 44.8% YoY to Rs. 151.7 cr: Prabhudas Lilladher Jul 12, 2019 05:00 PM IST

    Glenmark Pharma Q1 PAT may dip 44.8% YoY to Rs. 151.7 cr: Prabhudas Lilladher

    Net Sales are expected to increase by 5.6 percent Y-o-Y (down 11 percent Q-o-Q) to Rs. 2,247.9 crore, according to Prabhudas Lilladher.

  • Glenmark rallies 2% after Nomura re iterated rating on Torrent partnership Jul 12, 2019 12:10 PM IST

    Glenmark rallies 2% after Nomura re iterated rating on Torrent partnership

    Forming partnership with other large Indian companies for a novel drug is a solid strategy, Nomura said, adding upfront payment through partnership will recover a substantial portion of the development cost.

Sections